LOS ANGELES, June 07, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024 at 8:40 a.m. Eastern Time. There will be simultaneous and archived webcasts ava ...

Have you been paying attention to shares of RadNet (RDNT) ? Shares have been on the move with the stock up 20.6% over the past month. The stock hit a new 52-week high of $62.38 in the previous session. RadNet has gained 75.6% since the start of the year compared to the 6.1% move for the Zacks Medical sector and the 11.5% return for the Zacks Medical - Outpatient and Home Healthcare industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't missed our ...

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the tr ...

1 IF D H HT T 100 - 100 1 i T 1 Pgiam/iStock via Getty Images Investment Summary Shares of RadNet, Inc. (NASDAQ:RDNT) continue to offer extensive appeal to unlock risk capital for quality-oriented investors. Since my last publication on the company in July last year, the equity line has curled up more than 88%, and the position has compounded by 184% cumulatively since I first bought it for our portfolios in 2022. RadNet 12-month share price evolution Seeking Alpha RNDT's management is deploying capital at ...

RadNet (RDNT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. Since a changing ea ...

LOS ANGELES, June 03, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, will be presenting at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024 at 11:30 a.m. Eastern Time. There will be simultaneous and archived webcasts available at https:// ...

LOS ANGELES, June 03, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, will be presenting at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024 at 11:30 a.m. Eastern Time. There will be simultaneous and archived webcasts available at https:// ...

Exhibit 99.1 FOR IMMEDIATE RELEASE RadNet Reports First Quarter Financial Results with Record First Quarter Revenue, Adjusted EBITDA and Adjusted Earnings and Revises Upwards 2024 Financial Guidance Ranges · Total Company Revenue increased 10.5% to $431.7 million in the first quarter of 2024 from $390.6 million in the first quarter of 2023; Revenue from the Digital Health reportable segment increased 32.3% to $14.7 million in the first quarter of 2024 from $11.1 million in the first quarter of 2023 · Digita ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-33307 RadNet, Inc. (Exact name of registrant as specified in its charter) Delaware 13-3326724 (State or other j ...

财务数据和关键指标变化 - 总收入增长10.5%,其中影像中心业务收入增长9.9%,数字健康业务收入增长32.3% [1][2] - 调整后EBITDA增长21.4%,调整后EBITDA利润率提升120个基点 [1][2] - 每股调整后收益由负转正,由-0.22美元增长至0.07美元 [4] 各条业务线数据和关键指标变化 - 影像中心业务: - MRI检查量增长11.7%,CT检查量增长9.1%,PET/CT检查量增长17.5% [4] - 同店MRI、CT和PET/CT检查量分别增长9.9%、6.5%和15.3% [4] - 数字健康业务: - 收入增长32.3%,其中AI业务收入增长118.8% [2] - 调整后EBITDA大幅增长17,500% [4] 各个市场数据和关键指标变化 - 公司进入了新的德克萨斯州市场,完成了在休斯顿地区的7家影像中心收购,并宣布将收购6家American Health Imaging中心 [2][3] - 在加利福尼亚北部的Antelope Valley地区完成了4家中心的收购 [2] 公司战略和发展方向及行业竞争 - 公司继续通过收购和新建中心的方式扩张业务,2024年将有12家新开业的中心 [2][3] - 公司与医院和医疗系统的合资企业数量增加,目前已有137家中心(占比36.5%)通过合资方式运营 [3] - 公司加大在数字健康业务的投入,包括开发DeepHealth OS云端操作系统和生成式AI模块,以提高效率和降低成本 [6][7] - 公司在乳腺癌、前列腺癌和肺癌筛查等领域持续推进AI辅助诊断工具的应用,提高诊断准确性和效率 [6][7] 管理层对经营环境和未来前景的评论 - 公司受益于诊断影像在医疗行业的需求增加,以及从医院转向更低成本的独立影像中心的趋势 [1] - 公司与商业保险公司和按人头付费的支付方的谈判定价取得进展,提升了利润率 [8] - 公司看好先进影像检查(如MRI、CT和PET/CT)的增长前景,并将持续投资升级设备以提高产能 [8][9] - 公司认为数字健康业务将成为未来增长的重要驱动力,有望提高整体利润率 [6][7] 问答环节重要的提问和回答 问题1 **Brian Tanquilut 提问** 询问公司在定价方面的情况 [8] **Howard Berger 回答** 公司正在与支付方积极谈判,以获得更合理的定价,并在无法达成一致时选择转向收费制 [8] 问题2 **Andrew Mok 提问** 询问EBCD AI工具的采用率及其对影像中心效率的影响 [10][11] **Howard Berger 回答** EBCD AI工具在东海岸的采用率已达40%,未来有望进一步提高;该工具可以提高放射科医生的诊断准确性和工作效率 [10][11] 问题3 **Yuan Zhi 提问** 询问公司在不同州市场的份额差异及未来拓展的标准 [13] **Mark Stolper 回答** 公司的目标是在各个市场实现规模效应,而不是追求特定的市场份额;未来将继续通过收购和新建中心的方式扩张业务 [13]